维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="MA Sendur"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Evaluation of the renal func- tion using cystatin C level in the patients receiving cisplatin-based chemotherapy显示文摘	Kos FT Sendur MA Aksoy S	2013	Ren Fail2013，35，5：	1
2	Variations in tumor marker levels in metastatie breast cancer patients according to tumorsubtypes显示文摘	T Kos S Aksoy MA Sendur	2013	J BUON2013，18，3：	1
3	Everolimus: a new hope for patients with breast cancer显示文摘	Sendur MA Zengin N Aksoy S	2014	Curt Med Res Opin2014，30，1：	1
4	Demographic and clinicopathological characteristics of breast cancer patients with history of oral alendronate use显示文摘	Sendur MA Aksoy S Yaman S	2012	Med Oncol2012，29，4：	1
5	Can targeted pro- grammed death-1 antibody be a new treatment approach in breast cancer显示文摘	Sendur MA Aksoy S Demirci S	2014	J BUON2014，19，2：	1
6	Acupuncture as a com- plementary treatment for cancer patients receiving chem-otherapy 显示文摘	Tas D Uncu D Sendur MA	2014	Asian Pac J Cancer Prey2014，15，7：	1
7	Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma显示文摘	Sendur MA Aksoy S Ozdemir NY	2014	Indian J Pharmacol2014，14，1：	1
8	Can all beta blockers improve the breast cancer survival显示文摘	Sendur MA Aksoy S Yaman S		0，，：	1
9	Everolimus : A new hope for patients with breast cancer显示文摘	Sendur MA Zengin N Aksoy S	2014	Curr Med Res Opin2014，30，1：	1
10	Evaluation of the renal function using cystatin C level in the patients receiving cisplatin-based chemotherapy显示文摘	Kos FT Sendur MA Aksoy S	2013	Ren Fail2013，35，5：	1
11	Dcmograpldc and clinico- pathological characteristics in patients with invasive breast cancer receiving metformin显示文摘	Aksoy S Sendur MA Altundag K	2013	Med Oncol2013，30，2：	1
12	Everolimus:A new hope for patients with breast cancer显示文摘	Sendur MA Zengin N Aksoy S	2014	Curr Med Res Opin2014，30，1：	1
13	Everolimus : a new hope for patients with breast cancer显示文摘	Sendur MA Zengin N Aksoy S	2014	Curr Med Res Opin2014，30，：	1
14	Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer 显示文摘	Boyraz B Sendur MA Aksoy S	2013	C urr Med Res Opin2013，29，4：	1
15	Pertuzumab-indueed cardiotoxicity: safety compared with trastuzumab 显示文摘	Sendur MA Aksoy S Altundag K	2015	Future Oncol2015，11，1：	1
16	Pertuzumab in HER2 -positive breast cancer 显示文摘	Sendur MA Aksoy S Altundag K	2012	Curr Med Res Opin2012，28，10：	1
17	Everolimus: a new hope for patients with breast cancer显示文摘	Sendur MA Zengin N Aksoy S	2014	Curt Med Res Opin2014，30，1：	1
18	Capecitabine/cispl atin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breastcarcinoma patients 显示文摘	Ozdemir N Aksoy S Sendur MA	2013	J BUON2013，18，4：	1
19	Trastuzumab emtansine ( T- DM1 ) for HER2-positive breast cancer显示文摘	Boyraz B Sendur MA Aksoy S	2013	Cttrr Med Res Opin2013，29，4：	1
20	Can targeted programmed death-1 antibody be a new treatment approach in breast cancer显示文摘	Sendur MA Aksoy S Demirci S	2014	J BUON2014，19，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示